Home
Login Register
Biosensors   

Is Biosensors a good buy?

 Post Reply 1741-1760 of 10899
 
yiming2000
    16-Jul-2012 21:58  
Contact    Quote!


Susan66 - Are you still holding on? It is now 1.24 and I am still down $4,900 on my 20 lots. Smiley 126

You got in at 1.185. How many lots?    Smiley 77
 
 
infancybird
    16-Jul-2012 19:40  
Contact    Quote!


1.    Just to share view from GS. Lately all houses recommended buying of BIG. A complete reversal of view.

  2. Today big buying volume of over a few millions  shares all transected within minutes before 5pm. Good indication big thing are coming  . Insiders are accumulating BIG. They seems to know thing we don`t know yet. 

 

#Biosensors: Goldman Sachs initiates at Buy with TP $1.48, says with the stock trading at a two year low and 19%
discount to global peers, it has fuly priced in a potential decline in Japan sales after the latest price cuts.
Believes the risk / reward is skewed to the upside based on potential for, i) strong growth in the EU (+8%), APAC /
Latam (+21%) and China (+15%), driving a 16% earnings CAGR over FY13-15e on mkt share gains, and ii) regulatory
approvals for BioFreedom in the EU and BioMatrix in China, which would be catalysts for re-rating.



infancybird      ( Date: 12-Jul-2012 11:54) Posted:



Yes well done. Go to their AGM and question them.

  Looking at the share price, there is obviously a constant large sales block install at $1.20.....I guess the price will stagnate here till after their AGM on 26th Jul. Looks like the new share issue to whoever  for their M& A will   be priced at $1.20 or lower. We smaller holders are defenceless with this gp of BB constant manipulation. Only hope share price can move up after that. ....need to wait long long.

tbt001      ( Date: 12-Jul-2012 11:45) Posted:



I intend to attend the AGM.  I am OK with the share buyback (although I think it will have minimal impact on the share price in the long run) but I am against enlarging the capital base.  I am more interested in finding out about more important things:

-  how is the AXXESS stent doing?  more trial results? sales in Europe?  FDA approval?


-  how is BioFreedom doing?  status of CE Mark and FDA registration?  more trial results?

-  what is the status of SFDA registration for BioMatrix?  where are we on the official timeline?

-  what is the market share for the Nobori stent in Japan?

Please try to join me at the AGM.


 
 
ricourean
    16-Jul-2012 17:00  
Contact    Quote!


What's up.

 
 

 
ricourean
    16-Jul-2012 16:59  
Contact    Quote!
Here we go again. trying to go up
 
 
yeeen123
    16-Jul-2012 14:53  
Contact    Quote!
Actually how u all know whether this stock got AGM coming up? U all got letter? I didn't. Or cos I am a very minor stakeholder (2 lots), tt's why I didn't get letter. But I rmb getting once for another stock I held only 2 lots, I sold tt stock alr.
 
 
star-trader
    15-Jul-2012 15:54  
Contact    Quote!


Based on the chart, it doesn't have long black candlesticks which means that " buy-if" alert still exist and it is not in the selling mode zone.

Star-Trader 
 

 
TradeChancellor
    14-Jul-2012 22:29  
Contact    Quote!
the 2-year support/resistance pt is about $1.25...
 
 
topdog22
    13-Jul-2012 21:08  
Contact    Quote!
YES, since the company wants a share repurchase program those shares are used.  I know there may not be enough for the acquisition and in that case the company may have to issue additional shares.  This could make the acquisition accretive to earnings per share which helps the value   not dilutive which hurts  the value   
 
 
yeeen123
    13-Jul-2012 10:12  
Contact    Quote!
Ok... how do they get repurchased shares? The existing shareholders who hold shares sell theirs?

topdog22      ( Date: 13-Jul-2012 07:13) Posted:



By using repurchased shares - the stock price is supported by the share repurchase and the existing shareholders do not suffer as much dilution by issuing new shares.  The reason it is NOT better  to issue additional shares as the more shares issued means the more shares that must be used in the calcultaion of earnings per shares EPS.    Analyst evaluate the value of a company and its price target by multiplying the earnings per share by a multiplier based on similar  traded companies.    The share price  times the number of shares equals the total value of the company i.e. capitalization.

OK?

 
 
topdog22
    13-Jul-2012 07:13  
Contact    Quote!


By using repurchased shares - the stock price is supported by the share repurchase and the existing shareholders do not suffer as much dilution by issuing new shares.  The reason it is NOT better  to issue additional shares as the more shares issued means the more shares that must be used in the calcultaion of earnings per shares EPS.    Analyst evaluate the value of a company and its price target by multiplying the earnings per share by a multiplier based on similar  traded companies.    The share price  times the number of shares equals the total value of the company i.e. capitalization.

OK?
 

 
yeeen123
    12-Jul-2012 13:51  
Contact    Quote!


How to attend their AGM? I didn't receive any letter abt it yet.

 

"   why not use the repurchased shares for acquisitions, instead of issuing new shares especially without a valid reason"

What is using repurchased shares for acquisitions? And how does it differ fr issuing new shares? 

infancybird      ( Date: 11-Jul-2012 07:46) Posted:

Best way to answer all the questions raised is to attend their 26th AGM and SGM at Regent Hotel 10:00am to   check out who are the BBs and why they do this and  that. You may possibly get your answers on 25th  night too if you call their post- 1st Quater live  announcement tele-conference hotline.  I may pro share buyback(frighten away the short sellers)  and pro share issue( may be it is issured  at  the closing price based on last three or six months average as the BB has been suppressing the share price for about five months since Feb 2012 to  achieve their internally agreed secret fix price)  . My ``final wait`` has come.

topdog22      ( Date: 11-Jul-2012 06:58) Posted:



If one takes the position that a share buy back is valid, which it can be in certain circumstances.  It is  primarily used in countries with high tax rates on dividends but low tax rates on capital gains and is normally employed by very large companies with very LARGE cash hordes like Microsoft who until recently did not pay a dividend  or by tech companies who have slowing growth and  no dividend.  BIG is fast growth company and does NOT have huge amounts of cash.  A steady dividend supports the stock price, look at JNJ, BMY, LLY and then look at BSX (a loser)  If they buyback shares, why not use the repurchased shares for acquisitions, instead of issuing new shares especially without a valid reason.

 


 
 
infancybird
    12-Jul-2012 11:54  
Contact    Quote!


Yes well done. Go to their AGM and question them.

  Looking at the share price, there is obviously a constant large sales block install at $1.20.....I guess the price will stagnate here till after their AGM on 26th Jul. Looks like the new share issue to whoever  for their M& A will   be priced at $1.20 or lower. We smaller holders are defenceless with this gp of BB constant manipulation. Only hope share price can move up after that. ....need to wait long long.

tbt001      ( Date: 12-Jul-2012 11:45) Posted:



I intend to attend the AGM.  I am OK with the share buyback (although I think it will have minimal impact on the share price in the long run) but I am against enlarging the capital base.  I am more interested in finding out about more important things:

-  how is the AXXESS stent doing?  more trial results? sales in Europe?  FDA approval?


-  how is BioFreedom doing?  status of CE Mark and FDA registration?  more trial results?

-  what is the status of SFDA registration for BioMatrix?  where are we on the official timeline?

-  what is the market share for the Nobori stent in Japan?

Please try to join me at the AGM.

 
 
tbt001
    12-Jul-2012 11:45  
Contact    Quote!


I intend to attend the AGM.  I am OK with the share buyback (although I think it will have minimal impact on the share price in the long run) but I am against enlarging the capital base.  I am more interested in finding out about more important things:

-  how is the AXXESS stent doing?  more trial results? sales in Europe?  FDA approval?


-  how is BioFreedom doing?  status of CE Mark and FDA registration?  more trial results?

-  what is the status of SFDA registration for BioMatrix?  where are we on the official timeline?

-  what is the market share for the Nobori stent in Japan?

Please try to join me at the AGM.
 
 
junction
    11-Jul-2012 21:51  
Contact    Quote!


I cannot trust this board, chairman and ceos.  Anybody knows where I can send my proxy to vote against most of their resolutions, especially their remuneration, just to show them they are not trusted but I would support share buyback since they have been accumulating cash the last couple of years. I also  suspect they are cooking something to sell shares cheap to their corporate friends and leave out the retail investors yet again.  After the done deal they will push up the price again as they have been doing all the time. Will SGX investigate them?  Probably sleeping.

infancybird      ( Date: 11-Jul-2012 07:46) Posted:

Best way to answer all the questions raised is to attend their 26th AGM and SGM at Regent Hotel 10:00am to   check out who are the BBs and why they do this and  that. You may possibly get your answers on 25th  night too if you call their post- 1st Quater live  announcement tele-conference hotline.  I may pro share buyback(frighten away the short sellers)  and pro share issue( may be it is issured  at  the closing price based on last three or six months average as the BB has been suppressing the share price for about five months since Feb 2012 to  achieve their internally agreed secret fix price)  . My ``final wait`` has come.

topdog22      ( Date: 11-Jul-2012 06:58) Posted:



If one takes the position that a share buy back is valid, which it can be in certain circumstances.  It is  primarily used in countries with high tax rates on dividends but low tax rates on capital gains and is normally employed by very large companies with very LARGE cash hordes like Microsoft who until recently did not pay a dividend  or by tech companies who have slowing growth and  no dividend.  BIG is fast growth company and does NOT have huge amounts of cash.  A steady dividend supports the stock price, look at JNJ, BMY, LLY and then look at BSX (a loser)  If they buyback shares, why not use the repurchased shares for acquisitions, instead of issuing new shares especially without a valid reason.

 


 
 
topdog22
    11-Jul-2012 07:55  
Contact    Quote!
wish I could attend, but will still be away on  business trip evaluating new investments perhaps you can go and get answers and share them with us
 

 
infancybird
    11-Jul-2012 07:46  
Contact    Quote!
Best way to answer all the questions raised is to attend their 26th AGM and SGM at Regent Hotel 10:00am to   check out who are the BBs and why they do this and  that. You may possibly get your answers on 25th  night too if you call their post- 1st Quater live  announcement tele-conference hotline.  I may pro share buyback(frighten away the short sellers)  and pro share issue( may be it is issured  at  the closing price based on last three or six months average as the BB has been suppressing the share price for about five months since Feb 2012 to  achieve their internally agreed secret fix price)  . My ``final wait`` has come.

topdog22      ( Date: 11-Jul-2012 06:58) Posted:



If one takes the position that a share buy back is valid, which it can be in certain circumstances.  It is  primarily used in countries with high tax rates on dividends but low tax rates on capital gains and is normally employed by very large companies with very LARGE cash hordes like Microsoft who until recently did not pay a dividend  or by tech companies who have slowing growth and  no dividend.  BIG is fast growth company and does NOT have huge amounts of cash.  A steady dividend supports the stock price, look at JNJ, BMY, LLY and then look at BSX (a loser)  If they buyback shares, why not use the repurchased shares for acquisitions, instead of issuing new shares especially without a valid reason.

 

 
 
topdog22
    11-Jul-2012 06:58  
Contact    Quote!


If one takes the position that a share buy back is valid, which it can be in certain circumstances.  It is  primarily used in countries with high tax rates on dividends but low tax rates on capital gains and is normally employed by very large companies with very LARGE cash hordes like Microsoft who until recently did not pay a dividend  or by tech companies who have slowing growth and  no dividend.  BIG is fast growth company and does NOT have huge amounts of cash.  A steady dividend supports the stock price, look at JNJ, BMY, LLY and then look at BSX (a loser)  If they buyback shares, why not use the repurchased shares for acquisitions, instead of issuing new shares especially without a valid reason.

 
 
 
yiming2000
    10-Jul-2012 22:03  
Contact    Quote!
Topdog22 has a point. Share buyback is a defensive play for mature companies but not for small enterprises on the growth path. Biosensors is giving me cause for concern. Who own this company anyway? What is the story?
 
 
dcang84
    10-Jul-2012 21:14  
Contact    Quote!
Nothing wrong with seeking a mandate for share buyback. With the macro picture as bleak as it already is, I think more companies with the resources will initiate SBB.
 
 
topdog22
    10-Jul-2012 21:13  
Contact    Quote!


Gentle people's:  Personally I believe that BIG should pay dividends instead of a stock buy-back.  The number of outstanding shares means that any buyback can only temporarily support the price but it will not have a meaningful impact on EPS as the number of shares outstanding after the buyback will still be huge.  Their proposal to issue additional shares causing the current shareholders to suffer significant dilution without first stating the definite use for these newly issued shares I believe exhibits  VERY POOR governance.  I have been and still am a long term  investor in BIG as I am in other health care and  drug companies because I believe that when faced with a buying decision, most people perfer to live.  These products are necessary where as  a new watch or  auto is NOT.  In conclusion the lack of transparency from BIG management, incomplete data on china approval, the wild price gyrations and other transparency issues  should be addressed soon for the bigger the company gets the more difficult it will be to determine managements effectiveness.     

 
 
Important: Please read our Terms and Conditions and Privacy Policy .